"The U. S. Drug Enforcement Administration (DEA) published in the Federal Register
a Notice of Proposed Rulemaking (NPRM) to move hydrocodone combination
products (HCPs) from Schedule III to Schedule II, as recommended by
the Assistant Secretary for Health of the U.S. Department of Health and
Human Services and as supported by the DEA’s own evaluation of
relevant data. This NPRM proposes to impose the regulatory controls
and sanctions applicable to Schedule II substances on those who handle
or propose to handle HCPs."
Read the proposed rule here.
No comments:
Post a Comment